Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
about
Targeted therapies in sarcomas: challenging the challengeH19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expressionEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionUnbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11Defining the gene expression signature of rhabdomyosarcoma by meta-analysis.Genomic imprinting: implications for human disease.Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragmentsPediatric Rhabdomyosarcoma.Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways.IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.Chest wall hamartoma with Wiedemann-Beckwith syndrome: clinical report and brief review of chromosome 11p15.5-related tumors.PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcomaInitial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program.Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targetsDNA methylation, imprinting and cancer.Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancerDisruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcomaMethylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal RhabdomyosarcomaInhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2.RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3Methylation similarities of two CpG sites within exon 5 of human H19 between normal tissues and testicular germ cell tumours of adolescents and adults, without correlation with allelic and total level of expression.The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.The role of IGF-1R in pediatric malignancies.Early life factors and risk of childhood rhabdomyosarcoma.Molecular and cellular biology of rhabdomyosarcoma.Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma.Caveolins in rhabdomyosarcomaRhabdomyosarcomas: an overview on the experimental animal models.Insulin-like growth factor-binding protein-6 and cancer.Parental imprinting regulates insulin-like growth factor signaling: a Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis.The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches.Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.Non-coding RNAs in muscle differentiation and musculoskeletal disease.
P2860
Q21285014-134804B5-5837-4B5E-9E14-A72129D9593BQ24682023-E2595E1F-8A3D-41D6-B339-6DB4988C3696Q26766149-1EA9A463-8211-467C-BE7B-4B7B011E3E74Q28366519-1EF280BE-F4F9-45B5-AC71-3B940B1059BBQ33262934-628A4A57-6EFA-451D-AB3E-8FBEEC6066DFQ33541538-D1550D5E-44C6-425A-A6CD-613F47464A6DQ33681805-B21766FD-219B-44C7-845C-AB7B4D0EBE63Q33842070-31A3C80D-4E00-4D25-BE43-9691A7A20F24Q33875930-76817A15-B128-4AB2-AAA6-8DE58B3BAF41Q33999643-556DD33B-57A3-42B6-AECB-233BB2566D59Q34162514-855FDAF3-E28C-42E6-A8B2-4871B1FD8309Q34250993-BBB59B8A-68DF-472D-B5E0-D25E30EBB9B8Q34292385-427239C0-E3F7-4B29-916D-7CDD77819EB7Q34363846-87D294E6-0E66-416B-8DA4-A136AA7AD2B3Q34414710-EB31B890-C150-4780-968D-FF10A9E56113Q34504946-170E720B-C193-40A5-869A-D5B67424073CQ34564994-D24EB396-35D8-4448-BDD2-77C28CA0E6D7Q34620502-30FE02B4-A0AC-46BD-BBD2-55CCD650650CQ34786119-8E83435D-9977-4BB8-9CB0-DC8DB2DB171AQ35764532-A5B86D8E-548B-42B5-AC51-F89FA5ACB88EQ35773492-1C36F943-0DB3-479D-865A-5AAA2F8A98F7Q35862571-BB8DDAB1-D7D6-4A6F-8765-B03E2C2ECEDDQ36040768-C4492A04-4BB6-45D2-93ED-484414F82160Q36105839-4FBAD15A-A8FA-4221-9606-5181CAE9989AQ36170917-9816D471-37FD-4D07-A1F5-C4642E0E7C22Q36640305-0A0A9F7B-9757-4FCF-91E9-BEE659ED5083Q36762442-F93DFDE0-5FA1-4DC1-991A-3E8A6DC2BF88Q36884276-D9B3AF4D-8AF1-4B34-81F7-A480600FC6F6Q37279733-6FD35FE4-7606-4E3E-A9F7-2969A9324A9FQ37290912-14FA771D-4EDD-4B88-844F-101057355E5BQ37372537-9DB95FD7-6048-4774-8887-20319CEEB547Q37630588-1ACE4869-94F3-4BD7-A036-151C290104B6Q37831148-94F98053-2976-4707-B9BD-30A93F91653BQ37894860-DEFD1B69-73E0-424D-8A37-0AEEAEEF7156Q37973827-8199A738-8469-46A1-AE15-4C1ABC495976Q38057775-9F9922A3-3365-462F-A90D-82FBEE011125Q38058419-C58E4A28-A17F-4659-B7C9-69A0C8A4E515Q38612221-4A3403B4-C2BC-460A-8250-BA7015A47870Q38785704-F5A3BCEC-8D94-4718-BFE3-760C8EC7AFF3Q38850158-BB0369DE-D6D6-42A9-A704-2F1AC72827AA
P2860
Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@ast
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@en
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@nl
type
label
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@ast
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@en
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@nl
prefLabel
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@ast
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@en
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@nl
P2093
P2860
P356
P1476
Activation of an imprinted all ...... implicated in rhabdomyosarcoma
@en
P2093
P2860
P304
P356
10.1172/JCI117344
P407
P577
1994-07-01T00:00:00Z